ClinicalTrials.gg
RecruitingNCT07198971TEMPOSUpdated Apr 9, 2026

Feasibility Study Incorporating Music Therapy to Optimise the Smoking Cessation Process Coordinated by a Tobacco Addiction Nurse in Smoking Patients Being Treated for Cancer

An interventional study of Music therapy in Cancer (With or Without Metastasis), sponsored by Institut du Cancer de Montpellier - Val d'Aurelle. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-04-09.

Sponsored by Institut du Cancer de Montpellier - Val d'Aurelle · Not applicable, Interventional, and Other

How we know

From the registry’s dates

  • Started Feb 2026; still recruiting 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
26
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The innovative nature of this project lies in the combination of three types of intervention: tobacco addiction treatment, music therapy and therapeutic education.

Three disciplines that work together.

  1. Tobacco addiction treatment: reducing consumption, quitting,
  2. Music therapy: acting on emotions and reward circuits,
  3. Therapeutic education: promoting independent healthy practices. Patients learn to use the soundtrack independently to help them manage withdrawal symptoms caused by reducing or stopping tobacco consumption.

In this programme, patients play an active role on several levels:

  • working with the music therapist to create a personalised 'soundtrack';
  • identifying situations in which music can help them manage withdrawal symptoms;
  • using music independently in their everyday lives. The music therapy protocol will be proposed in this study, the soundtrack is co-created by the music therapist and the patient based on the patient's musical tastes and needs. The fact that the patient can use the musical tool independently also gives them significant leverage in their withdrawal process, allowing them to act on withdrawal symptoms and the main factors contributing to relapse.
Read the detailed description

Music therapy could address the three elements mentioned above:

  • add a practitioner other than the tobacco specialist,
  • increase the patient's perception of self-efficacy,
  • provide the patient with a personalised soundtrack that may have an effect on withdrawal symptoms associated with smoking cessation.

Music therapy could increase the chances of successful cessation. It therefore seems innovative to offer an educational intervention combining the tobacco specialist nurse and the music therapist, which would enable patients to use a musical tool co-developed with the music therapist independently at home. There are no data on the learning and use of such a tool to reinforce self-efficacy in managing smoking cessation. The analysis of the existing literature is poor in terms of music therapy and addiction and virtually non-existent in terms of tobacco addiction.

The objective is to evaluate the feasibility of an intervention combining tobacco addiction treatment and music therapy and its impact on smoking cessation symptoms in patients with cancer who smoke.

02

Conditions studied

  • Cancer (With or Without Metastasis)

Keywords

  • Smoking cessation
  • music therapy
  • tobacco addiction treatment
03

In context

Neoplasms

10,838 studies on the registry are indexed under Neoplasms; 2,322 are open to participants now.

This study's planned enrollment of 26 is below the median of 60 across 7,716 interventional studies indexed under Neoplasms.

Browse Neoplasms studies →

Lead sponsor

Institut du Cancer de Montpellier - Val d'Aurelle is the lead sponsor of 142 studies on the registry; 46 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients over the age of 18
  2. Patients with tobacco-related or non-tobacco-related cancer (excluding blood cancer)
  3. Patients who smoke daily
  4. Patients wishing to begin a smoking cessation programme
  5. Patients with a prognosis of > 1 year
  6. Patients who have given their informed, written and express consent
  7. Patients affiliated with a French social security scheme

Exclusion criteria

Exclusion Criteria:

  1. Patients with uncorrected hearing loss
  2. Patients with unstable psychiatric conditions
  3. Patients for whom regular follow-up is impossible for psychological, family, social or geographical reasons
  4. Patients under guardianship, curatorship or judicial protection
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
26 participants (estimated)

Study arms

  • Experimental
    EXPERIMENTAL

    Tabacco nurse consultation with music therapy session will be done at day 1 day 7 day 15 day 30 month 2 month 3 and month 6 (end of study)

    Other: Music therapy

Interventions

  • OtherMusic therapy

    Music therapy sessions in addition to nursing consultations: creation of a soundtrack to listen to in order to help quit smoking

06

What researchers measure

Primary outcomes

  1. Proportion of patients who adhered to the supervised sessions, combining follow-up by a tobacco addiction nurse and follow-up in music therapy

    The patient is considered compliant if they have participated in 4 or more of the 6 supervised sessions combining tobacco addiction consultations

    Time frame: From baseline to month 6

Secondary outcomes

  1. Tobacco use

    Number of cigarettes smoked per day and Measurement of exhaled CO and Tobacco dependence scale score: Simplified Fagerström Test

    Time frame: at baseline, at month 3, at month 6

  2. Withdrawal symptoms

    Scores on the Smoking Cessation Scale

    Time frame: at baseline, at month 3, at month 6

  3. The craving

    Scores obtained on the French Tobacco Craving Questionnaire

    Time frame: at baseline, at month 3, at month 6

  4. Motivation

    Scores on the 0-10 Digital Scale assessing motivation

    Time frame: at baseline, at month3, at month 6

  5. Confidence

    Scores on the EN assessing confidence

    Time frame: at baseline, at month 3, at month 6

  6. Sense of personal competence

    General Self Efficacy Scale questionnaire

    Time frame: at baseline, at month 3, at month 6

  7. Symptoms of anxiety and depression

    Anxiety and depression scores on the Hospital Anxiety and Depression Scale

    Time frame: at baseline, at month 3, at month 6

  8. Describe adherence to independent listening in music therapy between T2 and T6.

    Describe the number of times the patient listened to the audio recording per day, as recorded in a logbook.

    Time frame: at baseline, at month 3 and at month 6

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Benowitz NL. Neurobiology of nicotine addiction: implications for smoking cessation treatment. Am J Med. 2008 Apr;121(4 Suppl 1):S3-10. doi: 10.1016/j.amjmed.2008.01.015. PubMed 18342164 ↗
  • Jassem J. Tobacco smoking after diagnosis of cancer: clinical aspects. Transl Lung Cancer Res. 2019 May;8(Suppl 1):S50-S58. doi: 10.21037/tlcr.2019.04.01. PubMed 31211105 ↗
  • Kathuria H, Neptune E. Primary and Secondary Prevention of Lung Cancer: Tobacco Treatment. Clin Chest Med. 2020 Mar;41(1):39-51. doi: 10.1016/j.ccm.2019.10.002. PubMed 32008628 ↗
  • Tabac. (https://www.who.int/fr/news-room/fact-sheets/detail/tobacco). Accessed 7 December 2023.
  • Tabac - Réduire les risques de cancer. (https://www.e-cancer.fr/Comprendre-prevenir-depister/Reduire-les-risques-de-cancer/Tabac). Accessed 15 December 2023.

Individual participant data

Plan to share: Yes

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for Dec 2026, 10 months after the start.

Of 1,993 non-industry interventional studies with no phase under Neoplasms, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 52. This study's planned 10 months is below that.

Counting every sponsor, half of 2,068 studies reached it within 29 months; a quarter within 13 and three quarters within 52.

Neoplasms covers many different conditions, not one, so the studies compared here vary widely. Read these figures as a rough guide.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 9, 2025
First posted
Sep 30, 2025
StartActual
Feb 18, 2026
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Apr 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 9, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07198971
Responsible party
Sponsor
First posted
Sep 30, 2025
Start date
Feb 18, 2026
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Apr 9, 2026

Study contacts

Aude Menteaux Music therapist
Contact
aude.menteaux@icm.unicancer.fr
04 67 61 47 63
GONZALEZ Marie Laure, Tobacco Nurse
principal investigator · marie-laure.gonzalez@icm.unicancer.fr

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion